PATENT CLAIM ANALYSIS

Application Number: 15997028
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "364100"]

Abstract:
The present disclosure relates to solid crystalline forms of N—((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide (I) and the diastereomers thereof, and to methods for preparing such crystalline forms. Compound (I) and the diastereomers thereof are potent androgen receptor (AR) modulators useful as a medicament.

Claim (Index 8):
The process according to  claim 7 , wherein the acetonitrile:water mixture has a volume ratio from about 85:15 to about 99:1.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 94.0
- Lexical Diversity: 1.55814
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15997040', '15547193', '15564878', '14110596', '12561398']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7550400227205805
- 35 USC 102 Novelty (BERT): 0.5819116352701459
- Combined Prediction Score: 0.737727183975537
- Mean Citation Score: 401.092076
- Max Citation Score: 515.3943
- Similarity Product: 376.2907792080224

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test